Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database

Aya Hirata, Takumi Hirata, Yoshimitsu Takahashi, Takeo Nakayama

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: Surveillance is recommended for patients with risk of hepatocellular carcinoma (HCC) such as viral hepatitis and liver cirrhosis (LC). Although populations are at higher risk in Asia, surveillance rates have not been evaluated in those countries. Therefore, we aimed to examine surveillance rates for HCC and to compare predictors for surveillance among each type of liver disease in Japan. Methods: We carried out an observational study using the medical claims data of Japan. A total of 4713 patients who were diagnosed with LC, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection were followed for 12 months. We described surveillance rates in patients with HBV or HCV infection or non-viral LC and evaluated potential predictors for follow-up surveillance among them by using multivariable logistic regression analysis, in which we set explanatory variables as sex, age, medical facility, HBV or HCV infection, and LC. Results: The HCC surveillance rate during follow-up was 42.3% among patients with chronic viral hepatitis, 56.5% with viral cirrhosis and 26.0%, with non-viral LC. Significant predictors for follow-up surveillance were presence of LC and hospital visits. Hepatitis B virus-infected patients aged <50 years and HCV-infected patients aged ≥50 years were more likely to undergo exams, that is, different tendencies between HBV and HCV patients were shown. Conclusions: Follow-up surveillance for HCC was not adequately carried out among patients at risk for HCC in Japan, despite of recommendation in guidelines. In future, methodological research might be needed to increase surveillance rates for HCC in patients with chronic hepatitis or those who received treatment at a clinic.

Original languageEnglish
Pages (from-to)283-292
Number of pages10
JournalHepatology Research
Volume47
Issue number4
DOIs
Publication statusPublished - 2017 Mar 1

Fingerprint

Chronic Hepatitis B
Chronic Hepatitis C
Hepatocellular Carcinoma
Fibrosis
Databases
Liver Cirrhosis
Hepatitis B virus
Hepacivirus
Virus Diseases
Japan
Chronic Hepatitis
Hepatitis
Observational Studies
Liver Diseases
Logistic Models
Regression Analysis
Guidelines

Keywords

  • hepatocellular carcinoma
  • Japan
  • medical claims data
  • practice guidelines
  • surveillance

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database. / Hirata, Aya; Hirata, Takumi; Takahashi, Yoshimitsu; Nakayama, Takeo.

In: Hepatology Research, Vol. 47, No. 4, 01.03.2017, p. 283-292.

Research output: Contribution to journalArticle

@article{03725c0ae6094f0d8b996af0765e8531,
title = "Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database",
abstract = "Aim: Surveillance is recommended for patients with risk of hepatocellular carcinoma (HCC) such as viral hepatitis and liver cirrhosis (LC). Although populations are at higher risk in Asia, surveillance rates have not been evaluated in those countries. Therefore, we aimed to examine surveillance rates for HCC and to compare predictors for surveillance among each type of liver disease in Japan. Methods: We carried out an observational study using the medical claims data of Japan. A total of 4713 patients who were diagnosed with LC, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection were followed for 12 months. We described surveillance rates in patients with HBV or HCV infection or non-viral LC and evaluated potential predictors for follow-up surveillance among them by using multivariable logistic regression analysis, in which we set explanatory variables as sex, age, medical facility, HBV or HCV infection, and LC. Results: The HCC surveillance rate during follow-up was 42.3{\%} among patients with chronic viral hepatitis, 56.5{\%} with viral cirrhosis and 26.0{\%}, with non-viral LC. Significant predictors for follow-up surveillance were presence of LC and hospital visits. Hepatitis B virus-infected patients aged <50 years and HCV-infected patients aged ≥50 years were more likely to undergo exams, that is, different tendencies between HBV and HCV patients were shown. Conclusions: Follow-up surveillance for HCC was not adequately carried out among patients at risk for HCC in Japan, despite of recommendation in guidelines. In future, methodological research might be needed to increase surveillance rates for HCC in patients with chronic hepatitis or those who received treatment at a clinic.",
keywords = "hepatocellular carcinoma, Japan, medical claims data, practice guidelines, surveillance",
author = "Aya Hirata and Takumi Hirata and Yoshimitsu Takahashi and Takeo Nakayama",
year = "2017",
month = "3",
day = "1",
doi = "10.1111/hepr.12714",
language = "English",
volume = "47",
pages = "283--292",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database

AU - Hirata, Aya

AU - Hirata, Takumi

AU - Takahashi, Yoshimitsu

AU - Nakayama, Takeo

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Aim: Surveillance is recommended for patients with risk of hepatocellular carcinoma (HCC) such as viral hepatitis and liver cirrhosis (LC). Although populations are at higher risk in Asia, surveillance rates have not been evaluated in those countries. Therefore, we aimed to examine surveillance rates for HCC and to compare predictors for surveillance among each type of liver disease in Japan. Methods: We carried out an observational study using the medical claims data of Japan. A total of 4713 patients who were diagnosed with LC, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection were followed for 12 months. We described surveillance rates in patients with HBV or HCV infection or non-viral LC and evaluated potential predictors for follow-up surveillance among them by using multivariable logistic regression analysis, in which we set explanatory variables as sex, age, medical facility, HBV or HCV infection, and LC. Results: The HCC surveillance rate during follow-up was 42.3% among patients with chronic viral hepatitis, 56.5% with viral cirrhosis and 26.0%, with non-viral LC. Significant predictors for follow-up surveillance were presence of LC and hospital visits. Hepatitis B virus-infected patients aged <50 years and HCV-infected patients aged ≥50 years were more likely to undergo exams, that is, different tendencies between HBV and HCV patients were shown. Conclusions: Follow-up surveillance for HCC was not adequately carried out among patients at risk for HCC in Japan, despite of recommendation in guidelines. In future, methodological research might be needed to increase surveillance rates for HCC in patients with chronic hepatitis or those who received treatment at a clinic.

AB - Aim: Surveillance is recommended for patients with risk of hepatocellular carcinoma (HCC) such as viral hepatitis and liver cirrhosis (LC). Although populations are at higher risk in Asia, surveillance rates have not been evaluated in those countries. Therefore, we aimed to examine surveillance rates for HCC and to compare predictors for surveillance among each type of liver disease in Japan. Methods: We carried out an observational study using the medical claims data of Japan. A total of 4713 patients who were diagnosed with LC, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection were followed for 12 months. We described surveillance rates in patients with HBV or HCV infection or non-viral LC and evaluated potential predictors for follow-up surveillance among them by using multivariable logistic regression analysis, in which we set explanatory variables as sex, age, medical facility, HBV or HCV infection, and LC. Results: The HCC surveillance rate during follow-up was 42.3% among patients with chronic viral hepatitis, 56.5% with viral cirrhosis and 26.0%, with non-viral LC. Significant predictors for follow-up surveillance were presence of LC and hospital visits. Hepatitis B virus-infected patients aged <50 years and HCV-infected patients aged ≥50 years were more likely to undergo exams, that is, different tendencies between HBV and HCV patients were shown. Conclusions: Follow-up surveillance for HCC was not adequately carried out among patients at risk for HCC in Japan, despite of recommendation in guidelines. In future, methodological research might be needed to increase surveillance rates for HCC in patients with chronic hepatitis or those who received treatment at a clinic.

KW - hepatocellular carcinoma

KW - Japan

KW - medical claims data

KW - practice guidelines

KW - surveillance

UR - http://www.scopus.com/inward/record.url?scp=85016223198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016223198&partnerID=8YFLogxK

U2 - 10.1111/hepr.12714

DO - 10.1111/hepr.12714

M3 - Article

AN - SCOPUS:85016223198

VL - 47

SP - 283

EP - 292

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 4

ER -